Skip to main content
. 2004 Apr;48(4):1215–1221. doi: 10.1128/AAC.48.4.1215-1221.2004

FIG. 5.

FIG. 5.

Antibacterial efficacies and resistance profiles for S. pneumoniae containing the parC or parE mutation or both mutations after exposure to simulated human epithelial lining fluid levofloxacin concentrations. ▪, MIC for isolate 1312; ○, isolate 1312; □, MIC for isolate 1386; ▵, isolate 1386; shaded square, MIC for isolate 1610; ⋄, isolate 1610.